Aura Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aura Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q3 2024.
  • Aura Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $17.7M, a 9.33% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $17.7M -$1.83M -9.33% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $18.1M -$1.86M -9.31% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $18.5M -$1.84M -9.04% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $18.9M -$1.82M -8.79% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $19.6M -$1.43M -6.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $20M +$19.3M +2949% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $20.3M +$19.5M +2430% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $20.7M +$19.7M +2076% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $21M +$19.9M +1816% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $656K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $804K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $950K Dec 31, 2021 10-K 2023-03-15
Q3 2021 $1.1M Sep 30, 2021 10-Q 2021-11-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.